CPH 0.00% 0.9¢ creso pharma limited

Price, page-9

  1. 4,265 Posts.
    lightbulb Created with Sketch. 688
    Tbh, it seems pretty clear that the speculative money no longer sees a short- or medium-term future in the pot sector. Most companies are yet to earn any real money, and instead are burning millions in capex to compete in what is quickly becoming one of the most overcrowded markets that I can recall. The impacts on future profitability are increasingly clear, and the spec money is now bailing en masse looking for the next big thing.

    For CPH specifically, the 96% drop in wholesale sales/receipts over the last quarter also proved that its novelty products are likely to be a flop over the short- to medium-term, and hence success now hinges on winning in the extremely overcrowded market for growing flowers.

    Good luck guys.
    Last edited by FraserJC: 13/08/18
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.